Exposure of mcf-7 breast cancer cells to electromagnetic fields up-regulates the plasminogen activator system.
← Research streamMCF-7 cells exposed to a highly homogeneous 50-Hz EMF at 1.2 microT showed markedly increased expression of the urokinase plasminogen activator gene and plasminogen-activator inhibitor-1. Expression of the receptor for urokinase plasminogen activator was only…
Study snapshot
Abstract
Effects of electromagnetic fields (EMFs) on the incidence of breast cancer (BC) have been proposed by a number of epidemiological studies. The molecular mechanism of the impact of EMFs on cells is not yet clear, although changes in gene expression have been reported in various cellular systems. In this investigation, the interference of low-frequency EMFs with the plasminogen activator system was examined in BC cells.MCF-7 BC cells from 2 different sources were exposed to highly homogeneous 50-Hz EMFs. Changes in gene expression were analyzed by reverse transcriptase-polymerase chain reaction.In MCF-7 cells exposed to 1.2 microT EMF expression of the urokinase plasminogen activator gene and of plasminogen-activator inhibitor-1 was markedly increased. The expression of the receptor for urokinase plasminogen activator was only marginally increased in 1 of the 2 tested cell lines and expression of the tissue plasminogen activator was at least slightly down-regulated in BC cells exposed to EMFs.EMFs may be able to increase the metastatic potential of breast tumors. The use of our newly established exposure system for EMFs may allow us to study the signaling processes involved in the induction of a metastatic phenotype of breast cancer cells.
AI evidence extraction
Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.
Main findings
MCF-7 cells exposed to a highly homogeneous 50-Hz EMF at 1.2 microT showed markedly increased expression of the urokinase plasminogen activator gene and plasminogen-activator inhibitor-1. Expression of the receptor for urokinase plasminogen activator was only marginally increased in one of two tested cell lines, and tissue plasminogen activator expression was at least slightly down-regulated in EMF-exposed cells.
Outcomes measured
- Gene expression of urokinase plasminogen activator (uPA)
- Gene expression of plasminogen-activator inhibitor-1 (PAI-1)
- Gene expression of receptor for urokinase plasminogen activator (uPAR)
- Gene expression of tissue plasminogen activator (tPA)
Limitations
- In vitro study in a breast cancer cell line; clinical relevance not established in the abstract
- Exposure duration not reported in the abstract
- Sample size/number of replicates not reported in the abstract
- Only two MCF-7 sources/cell lines tested; some outcomes differed between them
View raw extracted JSON
{
"study_type": "in_vitro",
"exposure": {
"band": "ELF",
"source": null,
"frequency_mhz": 0.05,
"sar_wkg": null,
"duration": null
},
"population": "MCF-7 breast cancer cells (two different sources)",
"sample_size": null,
"outcomes": [
"Gene expression of urokinase plasminogen activator (uPA)",
"Gene expression of plasminogen-activator inhibitor-1 (PAI-1)",
"Gene expression of receptor for urokinase plasminogen activator (uPAR)",
"Gene expression of tissue plasminogen activator (tPA)"
],
"main_findings": "MCF-7 cells exposed to a highly homogeneous 50-Hz EMF at 1.2 microT showed markedly increased expression of the urokinase plasminogen activator gene and plasminogen-activator inhibitor-1. Expression of the receptor for urokinase plasminogen activator was only marginally increased in one of two tested cell lines, and tissue plasminogen activator expression was at least slightly down-regulated in EMF-exposed cells.",
"effect_direction": "mixed",
"limitations": [
"In vitro study in a breast cancer cell line; clinical relevance not established in the abstract",
"Exposure duration not reported in the abstract",
"Sample size/number of replicates not reported in the abstract",
"Only two MCF-7 sources/cell lines tested; some outcomes differed between them"
],
"evidence_strength": "very_low",
"confidence": 0.74,
"peer_reviewed_likely": "yes",
"keywords": [
"ELF-EMF",
"50 Hz",
"1.2 microT",
"MCF-7",
"breast cancer cells",
"plasminogen activator system",
"uPA",
"PAI-1",
"uPAR",
"tPA",
"gene expression",
"RT-PCR"
],
"suggested_hubs": []
}AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.
Identifiers and source
DOI: 10.1111/igc.0b013e31819f53ec
PubMed: 19407555
Related papers
- Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields. 2010
- A 50 Hz magnetic field influences the viability of breast cancer cells 96 h after exposure 2022
- [Effects of GSM 1800 MHz radiofrequency electromagnetic fields on protein expression profile of human breast cancer cell MCF-7]. 2006
- Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells. 1996
- Effects of repeated exposure to 50 Hz electromagnetic field on breast cancer cells. 2022
- Effects of extremely low-frequency electromagnetic field on expression levels of some antioxidant genes in human MCF-7 cells 2016